FibroGen, Inc. (NASDAQ:FGEN) Receives Consensus Recommendation of “Reduce” from Brokerages
Shares of FibroGen, Inc. (NASDAQ:FGEN – Get Free Report) have been assigned a consensus recommendation of “Reduce” from the six ratings firms that are covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation and four have assigned a hold recommendation to the company. The average 12-month target […]
More Stories
30 Ways Trump Impacted the US, World in First Year
By Travis Gillmore and Cathy He WASHINGTON—President Donald Trump used his first year back in the White House to set...
100-Vehicle Pileup Closes Michigan Interstate During Snowstorm
By Kimberly Hayek More than 100 vehicles—including over 30 semi trucks, some jackknifed—were involved in a massive pileup on Interstate...
It’s ‘Very Unlikely’ Supreme Court Will Overturn Trump’s Tariffs, Bessent Says
By Jack Phillips Treasury Secretary Scott Bessent on Jan. 18 said he believes it’s unlikely the U.S. Supreme Court will...
FBI Announces $100,000 Reward After Government Vehicles Broken Into in Minneapolis
By Jack Phillips The FBI said it is offering a reward of up to $100,000 for information leading to the...
Putin Invited to Join Gaza Board of Peace, Kremlin Says
By Guy Birchall The Kremlin confirmed on Jan. 19 that Russian President Vladimir Putin had been invited to join U.S....
Iran Protest Death Toll Nears 4,000, Human Rights Group Says
By Guy Birchall The U.S.-based Human Rights Activists News Agency (HRANA) said on Jan. 18 that it estimates at least...